MetaVia is trading 5.06% higher at $1.66, with no clear company-specific catalyst identified for September 18, 2026.
- The latest identifiable company news was September 9 preclinical data concerning DA-1726, which predates today’s move.
- Broader market sentiment may be contributing, although today’s major indexes are slightly lower.